Temobel, capsules 20 mg, 100 mg and 250 mg




Composition: each capsule contains:

active ingredients: temozolomide – 20 mg, 100 mg or 250 mg.

Therapeutic indications

Adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy.

Children over the age of 3 years and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.


АТС code


Pharmaceutical form

capsules 20 mg, 100 mg, 250 mg

Storage conditions

Store in protected from moisture and light place at temperature below 25°C.